Brand: Kaisahealth Group Holdings Limited Kaisahealth Group is dedicated to revolutionizing the healthcare industry in China as a comprehensive platform. Under Kaisa Group, it oversees investments, financing, operations, and management in the healthcare sector. The company comprises a Hong Kong-listed entity (stock code: 00876HK) and a main-board listed company (stock code: 000403SZ).

Their core businesses span pharmaceuticals, medical devices, and healthcare services. In the pharmaceutical realm, Kaisahealth holds rare licenses and focuses on high-end biopharmaceuticals and specialized anesthetics. Notable acquisitions include majority stakes in Qinghai Pharmaceutical Factory and a significant share in Shuanglin Biotech.

Within the medical devices segment, their "Meijia" line stands out as China's pioneer in dental instruments. By integrating cutting-edge dental technologies and a focus on digital aesthetics, Meijia provides painless, non-invasive digital dental solutions. Their flagship product, ultra-thin veneers, boasts a 90% market share in China.

Additionally, Kaisahealth excels in healthcare services with And Jia Rehabilitation Centers offering personalized and quality medical care. Through innovative products and service offerings, Kaisahealth Group is committed to enhancing human health and leading the way in the healthcare sector